Drug Profile
Research programme: micribial extracts - NAICONS
Alternative Names: NAI 414; nai 414-A; NAI 414-A; nai 414-B; NAI 414-B; OrthoformimycinLatest Information Update: 28 Jan 2020
Price :
$50
*
At a glance
- Originator NAICONS
- Class Anti-infectives
- Mechanism of Action DNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Gram-negative infections; Solid tumours
Most Recent Events
- 28 Jan 2020 No recent reports of development identified for preclinical development in Gram-negative-infections in Italy
- 28 Jan 2020 No recent reports of development identified for preclinical development in Solid-tumours in Italy
- 02 Dec 2015 Preclinical trials in Gram-negative infections in Italy (unspecified route)